INNT
TOTAL INVALIDATION PROCESSED BY THE IB
07/31/2020
Back to search
Official data from USPTO
DROSSA PHARM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
07/31/2020
Trademark type
Combined
Nice classes
3, 5
Filing date
05/07/2012
Registration date
03/05/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/11/2019
Last transaction
10/11/2019
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
CH
Examiner
COWARD, KATHRYN E
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "DROSSA PHARM" in the color black with two wavy lines between the words "DROSSA PHARM" the first wavy line is red and the second is blue.
Holders and representatives
Holders
Drossapharm AG
Representatives
Richard M. Goldberg Goldberg Patent Law Office
Technical classification
Nice Classes
Class 3Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Cosmetics
Class 5
Proprietary medicines in the nature of pharmaceutical preparations for the treatment of skin and scalp diseases and disorderspharmaceutical preparations for the treatment of mouth diseasespharmaceutical preparations for the treatment of rheumatic diseasespharmaceutical preparations for the treatment of the musculoskeletal systempharmaceutical preparations for the treatment of the cardio-vascular system
Publications
History of USPTO decisions and trademark events.
34 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
07/01/2020
INPC
INVALIDATION PROCESSED
07/01/2020
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
06/11/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
01/09/2020
C71T
CANCELLED SECTION 71
10/11/2019
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/05/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/30/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/06/2013
FIMP
FINAL DISPOSITION PROCESSED
06/06/2013
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/05/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/18/2012
PUBO
PUBLISHED FOR OPPOSITION
12/18/2012
GPNX
NOTIFICATION PROCESSED BY IB
12/14/2012
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/28/2012
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/28/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/28/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
11/15/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/15/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2012
ALIE
ASSIGNED TO LIE
10/19/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/09/2012
RFNT
REFUSAL PROCESSED BY IB
10/07/2012
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/30/2012
RFRR
REFUSAL PROCESSED BY MPU
08/30/2012
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/30/2012
CNRT
NON-FINAL ACTION WRITTEN
08/29/2012
DOCK
ASSIGNED TO EXAMINER
08/28/2012
MAFR
APPLICATION FILING RECEIPT MAILED
07/24/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/19/2012
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/13/2012
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/13/2012
Continuous trademark protection
Get notified about every new filing that threatens DROSSA PHARM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.